Horizon Therapeutics Public Ltd Co

CAPTRUST FINANCIAL ADVISORS

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/15/2023

Shares

4,444

Value ($000)

514

Weight

0.0%

2020 Q2 - 2023 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/15/2023	514	0.0%	4,444	9/30/2023
2023 Q2	8/15/2023	459	0.0%	4,461	6/30/2023
2023 Q1	5/15/2023	429	0.0%	3,934	3/31/2023
2022 Q4	2/15/2023	587	0.0%	5,160	12/31/2022
2022 Q3	11/16/2022	298	0.0%	4,818	9/30/2022
2022 Q2	8/23/2022	649	0.0%	8,137	6/30/2022
2022 Q1	5/16/2022	665	0.0%	6,325	3/31/2022
2021 Q4	2/14/2022	830	0.0%	7,706	12/31/2021
2021 Q3	11/16/2021	768	0.0%	7,007	9/30/2021
2021 Q2	8/16/2021	627	0.0%	6,694	6/30/2021
2021 Q1	5/17/2021	460	0.0%	4,994	3/31/2021
2020 Q4	2/16/2021	74	0.0%	1,018	12/31/2020
2020 Q3	11/17/2020	83	0.0%	1,038	9/30/2020
2020 Q2	8/14/2020	59	0.0%	1,074	6/30/2020